Intrauterine (extraamniotic) prostaglandins in the management of unsuccessful pregnancy.
Extraamniotic administration of prostaglandin E2 or prostaglandin F2alpha has been used in the treatment of 72 cases of unsuccessful pregnancy which included 50 of fetal death in utero, 13 of anencephaly and nine of hydatidiform mole. This management is highly effective in achieving abortion or delivery within 24 hours in almost all cases and results in few side effects. Pyrexia occurred during treatment in three patients, but in none was intrauterine infection observed. Blood loss greater than 250 ml occurred in only two patients, and none required transfusion. We advocate the use of extraamniotic prostaglandins as an active approach to the problem of unsuccessful pregnancy to relieve the patient of emotional distress and avoid the hazards of blood coagulopathy and intrauterine infection, both of which increase the longer a dead fetus is retained in utero.
D000019:Abortifacient Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D000028:Abortion, Induced / Q000009:adverse effects; D000030:Abortion, Missed; D000293:Adolescent; D000328:Adult; D000757:Anencephaly; D005260:Female; D005313:Fetal Death; D006801:Humans; D006828:Hydatidiform Mole; D007267:Injections; D011247:Pregnancy; D011458:Prostaglandins E / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D011460:Prostaglandins F / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D014599:Uterus
D000019:Abortifacient Agents; D011458:Prostaglandins E; D011460:Prostaglandins F